This week, our tour of recently published research of note in the HIV universe takes us past the following new landmarks:
- A huge gap between pre-exposure prophylaxis (PrEP) being indicated and PrEP being taken in the U.S. -- that is, among anyone who isn't a white male.
- An array of differences in antiretroviral therapy usage and viral suppression rates across HIV transmission categories in Europe.
- An examination of the effect that modern-era hepatitis C (HCV) treatments have had on mortality among people coinfected with HIV and HCV.
- An analysis highlighting sex-based differences in cognitive impairment among people with HIV -- particularly African Americans.
Let's take a few minutes to explore each of these studies a little more deeply. To beat HIV, you have to follow the science!
Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.
Myles Helfand is the executive editor and general manager of TheBody and TheBodyPRO. Follow Myles on Twitter: @MylesatTheBody.